COMPARATIVE STUDY
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Determining the cause of pulmonary atelectasis: a comparison of plain radiography and CT.

In a retrospective analysis of 50 patients with segmental or lobar atelectasis of the lung, chest radiographs and CT studies were compared for their abilities to distinguish whether a centrally obstructing tumor was the cause. This was done to help define the role of CT in evaluating patients with atelectasis. Atelectasis was caused by an obstructing tumor in 27 cases and a variety of other conditions in 23. The chest radiograph correctly identified an obstructing tumor as the cause of atelectasis in 24 of 27 patients on the basis of the presence of a central hilar mass or obvious bronchial abnormality; there was 89% sensitivity and 96% specificity with a 12% false-negative rate and a 4% false-positive rate. CT correctly identified all 27 obstructing carcinomas on the basis of the presence of either a central bronchial abnormality or a central hilar mass; there was 100% sensitivity and 87% specificity with a 0% false-negative rate and a 10% false-positive rate. Absence of air bronchograms or the presence of mucus-filled bronchi within the atelectatic lung were secondary CT findings that also favored the presence of an obstructing tumor. Although the chest radiograph was more specific than CT for tumor as the cause of atelectasis (96% vs 87%, respectively), it was less sensitive than CT for tumor (89% vs 100%, respectively) resulting in missed tumor diagnoses. CT identified all cases caused by obstructing tumor and successfully excluded obstructing tumor in most of the remaining cases, with an acceptable number of false-positive tumor diagnoses (10%). CT should be performed when the cause of segmental or lobar atelectasis cannot be established with certainty on the basis of the chest radiograph.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app